Pepgen INC Form 4 insider transactions

PepGen Inc. Chief Technical Officer Kasra Kasraian sold 1,233 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

PepGen's EVP, Head of R&D, Paul Streck, sold 1,879 shares of common stock to cover tax withholding obligations related to RSU vesting.

PepGen Inc.'s Chief Financial Officer, Noel Donnelly, sold shares to cover mandatory tax withholding obligations related to RSU vesting.

PepGen Inc.'s President and CEO, James G. McArthur, sold 5,275 shares of common stock to cover tax withholding obligations related to RSU vesting.

PepGen's Chief Business & Legal Officer, Joseph Vittiglio, acquired 30,717 restricted stock units and 120,000 stock options.

PepGen Inc.'s Chief Technical Officer, Kasra Kasraian, acquired 34,557 restricted stock units and 135,000 stock options on March 1, 2026.

PepGen Inc.'s EVP and Head of R&D, Paul Streck, was granted 50,300 restricted stock units and options to purchase 196,500 shares of common stock.

PepGen Inc.'s Chief Financial Officer, Noel Donnelly, reported the acquisition of 76,793 restricted stock units and 300,000 stock options, increasing his beneficial ownership.

PepGen Inc. President and CEO James G. McArthur was granted 187,688 restricted stock units and 731,250 stock options on March 1, 2026.

PepGen Inc. repriced 242,816 stock options for EVP Paul Streck, reducing the exercise price to $4.53 from $9.83, subject to retention.

PepGen Inc.'s Board of Directors approved a repricing of President and CEO James G. McArthur's stock options, reducing the exercise price to $4.53, subject to retention.

PepGen Inc.'s Chief Financial Officer, Noel Donnelly, had outstanding stock options repriced to an exercise price of $4.53 per share, effective November 4, 2025.

PepGen Inc.'s Chief Business & Legal Officer, Joseph Vittiglio, received 35,000 restricted stock units and options for 160,000 shares of common stock.

Oxford Science Enterprises plc acquired 200,000 shares of PepGen Inc. common stock, resulting in its beneficial ownership falling below 10% and ending its Section 16 reporting requirement.

RA Capital Management, L.P. and its affiliates acquired 9,375,000 shares of PepGen Inc. common stock for $3.20 per share, increasing their beneficial ownership to over 20 million shares.

RA Capital Management, a significant shareholder and director of PepGen Inc., reported the acquisition of 16,000 stock options for PepGen common stock at an exercise price of $1.51, granted to director Joshua Resnick.

PepGen Inc. Director Howard Mayer has acquired 16,000 stock options with an exercise price of $1.51, set to vest within one year or by the next Annual Meeting.

PepGen Inc. Director Heidi Henson has acquired 16,000 stock options with an exercise price of $1.51, which are set to vest fully by June 4, 2026, or the date of the next Annual Meeting.

PepGen Inc. Director Laurie Keating was granted 16,000 stock options with an exercise price of $1.51, aligning her interests with shareholder value.

PepGen Inc. Director Habib J. Dable has been granted 16,000 stock options with an exercise price of $1.51, aligning his interests with shareholder value.

PepGen Inc. director Joshua Resnick was granted 16,000 stock options with an exercise price of $1.51, though he disclaims personal beneficial ownership due to an arrangement with RA Capital Management, L.P.

PepGen Inc.'s EVP, Head of R&D, Paul Streck, acquired 8,375 shares of common stock at $1.241 per share through the company's Employee Stock Purchase Plan.

Chief Technical Officer of PepGen Inc., Kasraian Kasra, reports acquiring 16,750 shares of common stock and 75,000 stock options.

PepGen Inc.'s CEO, James G. McArthur, recently purchased 10,000 shares of common stock in the open market at an average price of $1.355 per share.

PepGen Inc.'s CEO, James G. McArthur, recently acquired 41,500 shares of common stock on the open market, signaling a potential vote of confidence in the company.

Director Mitchell H. Finer acquired 26,000 stock options in PepGen Inc. on March 27, 2025.

Director Lisa Wyman reports the acquisition of stock options in PepGen Inc.

Mary Beth DeLena, General Counsel of PepGen Inc., reports acquisition of common stock and stock options.

Chief Financial Officer Noel Donnelly of PepGen Inc. reports the acquisition of stock options and restricted stock units, along with the disposal of some common stock.

EVP and Head of R&D at PepGen Inc., Paul Streck, reports acquiring shares through restricted stock units and stock options.